First Quarter 2015 Review

Canadian Equity The Canadian stock market, represented by the S&P/TSX Composite, was up 2.6% in the first quarter of 2015. The best performing sector by a large margin was the health care sector. The Canadian health care sector is small and dominated by Valeant Pharmaceuticals, which rose by 50% following its purchase of US-based Salix Pharmaceuticals...

Fourth Quarter 2014 Review

Canadian Equity For the second consecutive quarter, the energy and materials sectors were a significant drag on performance as Canadian stocks declined by 1.5%. Falling oil prices was a major theme and hurt the stock price of oil and gas producers. It was not all bad, however, as the consumer staples, information technology and health care sectors each...

Third Quarter 2014 Review

Canadian Equity Canadian stocks fell by 0.6% during the quarter. Despite positive gains in the first two months, they were more than offset by negative results in September. The resource sectors were a significant drag on performance as the materials and energy sectors posted returns of -10.1% and -6.6% respectively. This was the result of falling commodity...

Second Quarter 2014 Review

Canadian Equity Canadian stocks were up 6.4% over the quarter, and continued to outperform the broader global market through 2014. In a reversal of recent trends, health care was the worst performing sector, declining 6.6%, largely driven by the performance of Valeant Pharmaceuticals. All other sectors posted positive gains with the energy and industrials...

Pages